with several specialized areas of patient management including a trauma center, a cancer center, a bone marrow transplant unit, and a liver transplant program, the results of approximately 40% of the blood specimens processed through the Coulter Gen•S (Beckman Coulter M) for CBC with differential are flagged for the presence of an abnormality and/or interference with measurement(s). The flagged automated results need to be verified by additional means, specifically, microscopic examination of a Wright-stained or Wright-Giemsa-stained blood smear with or without manual differential. Because these verification procedures are labor intensive, it is highly desirable that the automated flagging system be reliable.
A number of investigators, including us, have previously published data on the reliability of flags generated by various hematology analyzers including the Coulter STKS (Beckman Coulter M). [12] [13] [14] [15] [16] [17] [18] [19] [20] The purpose of this study was to assess the reliability in terms of sensitivity, specificity, efficiency, predictive value of normal (PVN), and predictive value of abnormal (PVA) of individual suspect flags (indicators of morphologic abnormalities) and regional or */R-flags (indicators of interference with the measurement) generated by the Coulter Gen•S, the latest large automated hematology analyzer from Beckman Coulter.
Material and Methods
Details of how the automated differential and CBC results are generated by the Coulter Gen•S have been published. 10 A number of proprietary, multifactorial rules, utilizing CBC data, Reliability (sensitivity, specificity, efficiency, predictive value of normal and predictive value of abnormal) of suspect flags (indicators of morphologic abnormalities) and regional flags (indicators of interference) generated by the Coulter Gen•S (Beckman Coulter M) Downloaded from https://academic.oup.com/labmed/article-abstract/32/6/310/2657172 by guest on 01 January 2019 ©̇y our lab focusï ndividual cell volume histograms (WBC, RBC, and PLT), and 3-dimensional WBC scattergrams (plots of impedance measurements vs light scatter and/or conductivity measurements), in various combinations, enable flagging of morphologic abnormalities and interference with measurements.
The WBC flags generated by the Coulter Gen•S include immature neutrophils 1 (INE1), immature neutrophils 2 (INE2), blasts (BL), variant lymphocytes (VL), and WBC interference flag (WBC-*). The Coulter Gen•S generates 3 types of blast flags, neutrophilic, monocytic, and lymphocytic. In this study, the presence of any 1 or more of these 3 flags was considered positive for the BL flag.
The RBC flags include nucleated red blood cells (NRBC), microcytic RBCs and RBC fragments (MRF), dimorphic RBC population (DIMOR), and RBC agglutination (RCA). The PLT flags include platelet clumps (CLP), giant platelets (GPL), and Rflag (PLT-R). An infrequently generated general flag, "verify diff," was not evaluated for lack of adequate data.
The study was conducted in 2 parts. In the first part, data were collected prospectively from 635 K 3 EDTA-anticoagulated blood specimens picked at random from the daily workload during a period of several days. Each specimen was processed through the Coulter Gen•S (software version 1C for both the analyzer and the data management system for the first part of the study, and 1D through 2A.2 with efficiency set at default of intermediate level for the analyzer and 2A for the data management system for the second part of the study) for CBC count and automated differential.
In our laboratory, the Coulter Gen•S was calibrated quarterly using SCal (Beckman Coulter M). Quality control was performed daily using 3 levels of 5C (Beckman Coulter M) per shift, according to manufacturer's instructions. 10 In addition, a manual differential was performed on a WrightGiemsa-stained peripheral blood smear prepared from each specimen within 2 hours of processing through the analyzer. Manual differential included a 100-cell differential, evaluation of WBC, RBC, and PLT morphologic features, and detection of any other pertinent finding(s).
Based Similarly, true abnormality for the DIMOR flag was defined in 2 ways. Initially, true dimorphism was defined as the presence of a hypochromic RBC population admixed with a normochromic RBC population (DIMOR-a), which was considered a practical definition with clinical significance. Alternatively, true dimorphism was defined as the presence of any 2 populations of RBCs, eg, microcytic and normocytic or microcytic and macrocytic (DIMOR-b). The alternative definition was considered theoretical with limited clinical significance. Discrepancies between automated flagging and the findings of corresponding manual differential performed by a technologist were resolved by repeated manual differential and/or review of the peripheral blood smear by one of the authors, all of whom are experienced morphologists.
The prevalence and relative distribution of individual flags were determined from data on a total of 1,066 specimens (635 from part one of the study and 431 from the routine workload processed through the Coulter Gen•S for CBC with automated differential on another day). The data from the additional 431 specimens were used solely to give added credence to the results obtained particularly For the second part of the study, data were collected retrospectively from the daily workload processed for CBC and differential (automated and manual) counts for a period of several months. Automated differential results accompanied by 1 or more flags were reviewed with the corresponding manual differential results until each qualitative abnormality (for sensitivity determination) and each flag (for PVA determination) was represented by 100 specimens. For determination of sensitivity from these data, each automated differential result was judged to be true abnormal if it was accompanied by a specific flag corresponding to the qualitative abnormality on the manual differential (eg, INE1 or INE2 flag for the presence of left shift, BL flag for the presence of blasts). A result was considered false normal if it was not accompanied by a flag or was accompanied by an inappropriate flag (eg, VL flag for the presence of left shift, INE1 flag for the presence of RBC fragments). For PVA determination, each automated flag was judged to be either true abnormal or false abnormal, based on specific findings on the blood smear [T1].
Sensitivity (percentage of true abnormals), specificity (percentage of true normals), efficiency (percentage of specimens correctly categorized as truly normal or abnormal), PVN, and PVA were calculated using the formulas in T3.
Results
The prevalence (flagging frequency) and relative distribution of individual flags are depicted in T2. The INE1 flag was most common (prevalence, 24.6%), and the GPL flag least common (0.8%). Data for frequency of 1 or more additional flags accompanying each flag generated are also illustrated in T2. Only a small percentage of specimens flagged for INE1 carried 1 or more additional WBC, RBC, and/or PLT flags. In contrast, one half or more of specimens flagged for any of the other WBC, RBC, or PLT flag carried 1 or more additional WBC, RBC, and/or PLT flags.
Sensitivity, specificity, efficiency, PVN, and PVA values were calculated for each of the suspect flags and regional PVAs calculated from data on flagged specimens are also either significantly greater than or similar to those obtained from data in the random specimen population for many of the evaluated automated flags. Some notable exceptions, however, include the relatively lower values of PVA for the DIMOR flag (DIMOR-a), 2% vs 27.3%, and the GPL flag (GPL-a), 29% vs 75%. The differences noted in the results from the 2 groups of data can generally be attributed to the differences in the nature (abnormal only vs random) and relative size (100 per abnormality or flag vs 635 total) of specimens within them. It is also possible that the change of software version (from 1C to 1D and 2A.2) between the 2 groups contributed to the noted differences.
Assessment of Reliability of Flags Generated by Coulter Gen•S*
An additional factor responsible for the difference in sensitivity of MRF flags between the 2 groups is that true abnormality in the random specimen population was defined as either the presence of microcytic RBCs (mean corpuscular volume <80 µm 3 [<80 fL], microcytosis of 1+ or more) or any degree of schistocytosis. In the other group, it was limited to the presence of schistocytosis of 1+ or more.
Discussion
In an ideal flagging system, the value for each assessed parameter (sensitivity, specificity, efficiency, PVN, and PVA) for each flag is at or near 100%. From a practical standpoint, however, reliability is often assessed in relative terms: the closer the values are to 100%, the more reliable the system. In our study, the PLT flags had the lowest sensitivity, and the RBC flags the highest. However, none of the flags' sensitivity approached 100%. The possibility that platelet clumping may have occurred in the interval between specimen processing through the analyzer and blood smear preparation and thereby contributed to the low sensitivity of 5.3% for the CLP flag and 19.4% for the PLT-R flag, though likely, can neither be confirmed nor excluded based on the available data.
Specificity was more than 96% for all flags except the INE1 flag (84.1% for the INE1 rel and 86.0% for the INE1 abs ). Efficiency of greater than or equal to 93% was obtained for all of the evaluated flags except the 2 left-shift flags, which revealed significantly lower efficiency (75.6% to 82.8%). PVN for all flags except the INE1 and INE2 flags ranged from 95% to 99.8%. The INE1 and INE2 flags' PVN were between 75.5% and 90.1%. Among the WBC suspect flags, PVA was lowest for the BL flag (56%) and VL flag (58%). Of the 2 leftshift flags, the INE2 flag had noticeably greater PVA, particularly when the true abnormality was defined in absolute terms. PVA for many of the RBC and PLT flags was at less than desirable levels.
Among the suspect flags related to RBCs, the DIMOR flag had the highest PVA (85%) when true dimorphism was defined as the presence of any 2 RBC populations. However when true dimorphism was defined as the presence of an admixture of hypochromic RBC population and normochromic RBC population, the DIMOR flag's PVA ranged from 2.0% to 27.3%. PVA for the NRBC flag increased from 46% to 51% when the definition of true abnormality was expanded to include the presence of any platelet clump(s) or giant platelet(s), because NRBCs, platelet clumps, and giant platelets are localized in approximation to each other on the WBC scattergram. The rarely generated RCA flag was not evaluated because of lack of adequate data. The PVAs of the 2 platelet-related suspect flags also increased significantly, from 16% to 66% for the CLP flag and from 29% to 74% for the GPL flag, when true abnormality for each flag was redefined as the presence of any platelet clump, giant platelet, or NRBC (CLP-b, GPL-b). Of the 2 regional flags, the WBC-* flag had significantly greater PVA (68%) than did the PLT-R flag (36%).
Inasmuch as the statistical data, particularly PVN and PVA, depend largely on the prevalence of the abnormality in the evaluated specimen population, pertinent data on flagging frequency are provided [T2]. The prevalence rates of flags understandably will vary among laboratories depending on specific patient populations.
Compared with previously published findings of a similar study conducted by the authors to assess the reliability of the flagging system of the Coulter STKS, 20 a predecessor of the Coulter Gen•S, sensitivity values were found to be lower and specificity values either similar or slightly greater for all of the flags generated by the Coulter Gen•S. Similarly, PVN for the Coulter Gen•S-generated flags were either similar to or relatively greater than previously reported values for the corresponding flags generated by the Coulter STKS. PVAs, on the other hand, were found to be relatively lower for the MRF, DIMOR, CLP, GPL, and WBC* flags; similar for the NRBC and PLT-R flags; and greater for the INE1, INE2, BL, and VL flags generated by the Coulter Gen•S.
Efficiency values for all but the INE1 and INE2 flags generated by the Coulter Gen•S were similar to previously reported values for the corresponding flags generated by the Coulter STKS. The Coulter Gen•S-generated INE1 and INE2 flags, whether defined in relative or absolute terms, revealed greater efficiency compared with the reported values for the corresponding flags generated by the Coulter STKS. Although the data on prevalence and relative distribution among themselves of flags generated by the Coulter Gen•S are similar to the corresponding data of flags generated by the Coulter STKS, overall percentage of CBC with differential specimens flagged by the Coulter Gen•S was found to be lower than the reported flagging rate of the Coulter STKS (40% vs 50%). Apparently the noted improvements in specificity, PVN, and PVA for many of the Coulter Gen•S-generated flags over the Coulter STKS-generated flags have come at a cost of lower sensitivity of a number of flags.
Previously reported studies of assessment of the flagging system of automated hematology analyzers, including the Coulter STKS, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] do address, as does this study, the need for further improvement in the reliability of the automated flagging system from the standpoint of clinical utility and costeffectiveness. Our observations suggest that the reliability and consequently the cost-effectiveness of the automated flagging system of the Coulter Gen•S could be specifically improved by enhancing the sensitivity and PVA of all flags, the specificity of the INE1 flag, and the PVN of the INE1 and INE2 flags. It is hoped that this article will encourage readers and the manufacturers of other automated hematology analyzers to conduct similar studies.
Conclusion
With efficiency of greater than or equal to 93%, PVN > 95%, and specificity > 96% for all flags but the 2 leftshift flags (INE1 and INE2) , the Coulter Gen•S automated flagging system is less than ideal but acceptable. The sensitivity of 10% to 86% and PVA of 16% to 85% for all flags, however, leave room for improvement toward increasing overall clinical reliability and cost-effectiveness.
